Michael Sinclair, Director, 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 60,000 shares at $12.52 ($751K) on 2019-09-12, disclosed to the SEC on 2019-09-13.
Open-market sale of $751k OPNT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OPNT | SELL | 2022-06-08 | $209K | — | Filing → |
| OPNT | SELL | 2022-06-06 | $549K | — | Filing → |
| OPNT | SELL | 2021-08-25 | $3.6M | — | Filing → |